References
1 Moses JW, Weisz G, Mishkel G, Caputo R, O`shaughnessey C,
et al. Catheterization and cardiovascular interventions Catheter Cardiovasc Interv 2007 70:505-512
2 Fontos G. Drug eluting coronary stents Orv Hetil 2006 147:2059-2066
3 Sutton AGC, Campbell PG, Graham R, Price DJA, Gray JC,
et al. One year results of the Middlesborough early revascularization to limit infarction (MERLIN) trial Heart (British Cardiac Society) 2005 91:1330-1337
4 Arjomand H, Turi Z, McCormick D, Goldberg S. Percutaneous coronary intervention: historical perspectives, current status, and future direction Am Heart J 2003 146:787-796
5 Jenkins NP, Predergast BD, Thomas M, Drug eluting coronary stents BMJ 2002 325:1315-1316
6 Bitl JA, Scwartz L, Serruys PW, Fischmann DL, Savage SP,
et al. Coronary-Stent placement compared with balloon angioplasty N Engl J Med 1995 332:536-538
7 Serruys PW, Jaegere PD, Kiemenij F, Macaya C, Rutsch W,
et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease N Engl J Med 1994 331:489-495
8 Grüntzig A. Transluminal dilatation of coronary-artery stenosis Lancet 1978 1:263
9 Palmaz JC, Richter GM, Noldge G, Kauffmann GW, Wenz WDR. Intraluminal Palmaz stent implantation. First clinical case report on a balloon-expanded vascular prosthesis Radiologe 1987 27:560-563
10 Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N Engl J Med 1987 316:701-706
11 Erbel R, Schatz R, Dietz U, Nixdorff U, Haude M,
et al. Balloon dilatation and coronary vascular stent implantation Z Kardiol 1989 78:71-77
12 Miller LA, Briscoe A, Bailey SR, Wright WT
Jr, Ebersole DG. Care of the elective intracoronary stent patient Crit Care Nurs Q 1996 18:777-791
13 Gerschlick AH, Baron J. Dealing with in-stent restenosis Heart 1998 79:319
14 Morice MA, Serruys PW, Sousa JE, Fajadet J, Hayashi EB,
et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 2002 346:1773-1780
15 Bhatia V, Bhatia R, Dhinkda SJ. Drug-eluting intra-coronary stents: Have we got the magic bullet J Postgrad Med 2003 49:291-296
16 Stone GW, Ellis SG, O`Shaughnessy CD,
et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents the TAXUS V ISR randomized trial JAMA 2006 295:1253-1263
17 Ratner BD. New ideas in biomaterials science, A path to engineered biomaterials J Biomed Mater Res 1993 27:837-850
18 Pinchuk L, Wilson GJ, Barry JJ, Schoephoerster RT, Parel JM,
et al. Medical applications of poly(styrene-
block-isobutylene-
block-styrene) (”SIBS”) Biomaterials 2008 29:448-460
19 Ven der Giessen W, Lincoff AM, Schwartz RS, van Beusekom HMM, Serruyset PW,
et al. Marked inflammatory sequalae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 1996 94:1690-1697
20 Pinchuk L. A review of the biostability and carcinogenicity of polyurethanes in medicine and the new generation of ‘biostable’ polyurethanes J Biomater Sci Polym Ed 1994 6:225-267
21 Wache HM, Tartakowska DJ, Hentrich A. Wagner: Development of a polymer stent with shape memory effect as a drug delivery system J Mater Sci Mater Med 2003 14:109-112
22 Muni NI, Gross TP. Problems with drug-eluting coronary stents- The FDA perspective N Engl J Med 2004 351:1593-1595
23 Weber F, Schneider H, Schwarz C, Holzhausen C, Petzsch M,
et al. Sirolimus- eluting stents for percutaneous coronary intervention in acute myocardial infarction Z Kardiol 2004 93:938-943
24 Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA,
et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 2007 50:1299-1304
25 Morice MA, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M,
et al. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization N Engl J Med 2002 346:1773-1780
26 Kennedy JP, Kaszas G, Puskas JE, Hager WG. Thermoplastic elastomers of isobutylene and process of preparation. U.S. Patent 4,946,899, August 7,
1990.27 Lawrence SS, Shinozaki DM, Puskas JE, Gerchcovich M, Myler U. Micro-mechanical testing of polyisobutylene-polystyrene block-type thermoplastic elastomers Rubber Chem. Technol. 2001 74:601-613
28 Puskas JP, Paulo C, Antony P. Arborescent thermoplastic elastomers and products therefrom. U.S. Patent 6,747,098, June 8,
2004.29 Cadieux P, Watterson JD, Harbottle R, Howard J, Puskas JE,
et al. A new biomaterial for application to the urinary tract, and potential for lactobacillus proteins to reduce the risk of device-associated infections J Colloids Surf B Biointerfaces 2002 28:95-105
30 Puskas JE, Chen Y, Antony P, Kwon Y, Kovar M,
et al. Atomic force microscopic and encrustation studies of novel prospective polyisobutylene-based thermoplastic elastomeric biomaterials Polym Adv Technol 2003 14:763-770
31 Antony P, Kwon Y, Puskas JE, Kovar M, Norton PR. Atomic force microscopic studies of polystyrene-polyisobutylene block copolymers Eur Polym J 2003 40:149-157
32 Puskas JE, Antony P, El Fray M, Altstädt V. Effect of hard and soft segment composition on the mechanical properties of polyisobutylene-polystyrene thermoplastic elastomeric block copolymers Eur Polym J 2003 39:2041-2049
33 Puskas JE, Chen Y. Biomedical application of commercial polymers and novel polyisobutylene-based thermoplastic elastomers for soft tissue replacement Biomacromolecules 2004 5:1141-1154
34 Puskas JE, Chen Y, Dahman Y, Padavan D. Polyisobutylene-based biomaterials. Feature article J Polym Sci Chem 2004 42:3091-3109
35 Kennedy JP, Puskas JE, Holden G, Kricheldorf HR, Quirk RP.
Thermoplastic Elastomers Hanser Publishers Munich 2004
36 Puskas JE, Kwon Y, Prince A, Bhowmick AK. Synthesis and characterization of novel dendritic(arborescent, hyperbranched) polyisobutylene-polystyrene J Polym Sci [A1] 2005 43:1811-1826
37 Puskas JE, Dos Santos L, Kaszas G. Innovation in material science: the chameleon block copolymer J Polym Sci Chem 2006 44:6494-6497
38 El Fray M, Prowans P, Puskas JE, Altstädt V. Biocompatibility and fatigue properties of polystyrene-polyisobutylene-polystyrene, an emerging thermoplastic elastomeric biomaterial Biomacromolecules 2006 7:844-850
39 Puskas JE, Kwon Y. Biomacromolecular engineering: desing, synthesis and characterization one-post synthesis of block copolymers of arborescent polyisobutylene and polystyrene Polym Adv Technol 2006 17:615-620
40 Foreman EA, Puskas JE, Kaszas G. Synthesis and characterization of arborescent (hyperbranched) polyisobutylenes from the 4-(1,2-oxirane-isopropyl)styrene inimer J Polym Sci Chem 2007 45:5847-5856
41 Turco MA, Ormiston JA, Popma JJ, Mandinov L, O`Shaughnessy CD,
et al. Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: the pivotal TAXUS ATLAS trial J Am Coll Cardiol 2007 49:1676-1683
42 Keiichi T, Serruys PW, Bruining N, Dudek D, Drzewiecki J,
et al. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial Am J Cardiol 2007 99:607-615
43 Moses JW, Mehran R, Nikolsky E, Lasala JM, Corey W,
et al. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial J Am Coll Cardiol 2005 45:1165-1171
44 Ranade SV, Richard RE, Helmus MN. Styrenic block copolymers for biomaterial and drug delivery applications Acta Biomater 2005 1:137-144
45 Ranade SV, Miller KM, Richard RE, Chan AK, Allen MJ, Helmus MN.
et al. Physical characterization of controlled release of paclitaxel from the TAXUSTM Express2TM drug eluting stent J Biomed Mater Res 2004 71A:625-634
46 Long D. DES2.0—and beyond.
AHC Media LLC Cardiovascular Device Update™ AHC Media 2007 13:1-7
47 Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T,
et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 2007 356:1009-1019
48 Galoe AM, Thuesen L, Kelbaek H, Thayssen P, Rasmussen K,
et al. Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial JAMA 2008 299:409-416
49 Blagosklonny MV, Darzynkiewicz Z, Halicka HD, Pozarowski P, Demidenko ZN. Paclitaxel induces primary and postmitotic g1 arrest in human arterial smooth muscle cells Cell Cycle 2004 3:1050-1056
50 Haude M, Erbel R, Straub U, Dietz U, Schatz R,
et al. Results of intracoronary stents for management of coronary dissection after balloon angioplasty Am J Cardiol 1991 67:691-696
51 Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S,
et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study Circulation 1991 83:148-161
52 Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ,
et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 2001 103:1967-1971
53 Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR,
et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 2003 349:1315-1323
54 Stone GW, Ellis SG, Cox DA, Hermiller J, O`Shaughnessy C,
et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 2004 350:221-231
55 Kereiakes DJ. The Emperor`s new clothes: another cipher versus taxus post-hoc meta-analysis J Am Coll Cardiol 2007 50:5
56 Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis J Am Coll Cardiol 2005 45:941-946
57 Pfisterer ME, Kaiser CA, Bader F, Brunner-La Rocca HP, Bonetti PO. BASKET-LATE: Late clinical events related to late stent thrombosis after stopping clopidogrel: Drug-eluting vs bare-metal stenting. In
American College of Cardiology 55th Annual Scientific Meeting, Atlanta, GA,
2006; Abstract 422-11.58 Camenzind E, Steg PG, Wijns W. A cause for concern Circulation 2007 115:1440-1455
59 Leon BM. Independent physician-led patient-level analysis: TAXUS randomized trials. In
Program and abstracts from the Transcatheter Cardiovascular Therapeutics 18th Annual Scientific Symposium, Washington, DC, October 22–27,
2006.60 Stone GW. Independent physician-led patient-level analysis: CYPHER randomized trials. In
Program and abstracts from the Transcatheter Cardiovascular Therapeutics 18th Annual Scientific Symposium, Washington, DC, October 22–27,
2006.61 Bavry AA, Bhatt DL. Appropriate use of drug-eluting stents: balancing the reduction restenosis with the concern of late thrombosis Lancet 2008 371:2134-2143
62 Marroquin OC, Mulukutla SR, Kip KE. Bare-metal versus drug-eluting coronary stents N Engl J Med 2008 358:2517-2518
63 Pierfrancesco A, Vermersch P. Bare-metal versus drug-eluting coronary stents New England J Med 2008 358:2516-2517
64 Austin D, Pell JP, Oldroyd KG. Bare-metal versus drug-eluting coronary stents N Engl J Med 2008 358:2516
65 Pui DYH, Chen DR. Electrospraying Apparatus and Method for Coating Particles. US Patent 6,746,869, June 8,
2004.
Comments
Post Your Comment